Clover Health Investments, Corp.
Income Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Revenue | $1.92B | $1.37B | $1.26B | $1.10B | $1.47B | $672.9M | $462.3M |
| Cost of Revenue | — | — | — | — | — | — | — |
| Gross Profit | — | — | $257.3M | $22.7M | $-79.2M | — | — |
| Gross Margin | — | — | 20.4% | 2.1% | -5.4% | — | — |
| Operating Expenses | |||||||
| Research & Development | — | — | — | — | — | — | — |
| SG&A Expense | $214.3M | $176.5M | $183.1M | $203.7M | $185.3M | $120.8M | $95.7M |
| Operating Income | $-85.5M | $-45.7M | $-205.3M | $-286.7M | $-637.0M | $-92.7M | $-183.2M |
| Operating Margin | -4.4% | -3.3% | -16.3% | -26.1% | -43.3% | -13.8% | -39.6% |
| Interest Expense | — | — | $7.0K | $1.3M | $3.2M | $36.0M | $23.2M |
| Pretax Income | $-85.5M | $-43.0M | $-213.4M | — | — | — | — |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income | $-85.5M | $-43.0M | $-213.4M | $-339.6M | $-587.8M | $-136.4M | $-363.7M |
| Net Margin | -4.4% | -3.1% | -16.9% | -31.0% | -39.9% | -20.3% | -78.7% |
| EPS (Basic) | $-0.17 | $-0.09 | $-0.44 | $-0.71 | $-1.42 | $-0.31 | $-0.83 |
| EPS (Diluted) | $-0.17 | $-0.09 | $-0.44 | $-0.71 | $-1.42 | $-0.31 | $-0.83 |
| Shares Outstanding (Basic) | 512.0M | 490.0M | 482.2M | 476.2M | 412.9M | 443.5M | 439.1M |
| Shares Outstanding (Diluted) | 512.0M | 490.0M | 482.2M | 476.2M | 412.9M | 443.5M | 439.1M |
| Dividends Per Share | — | — | — | — | — | — | — |